Document Detail


Lovastatin-induced apoptosis in prostate stromal cells.
MedLine Citation:
PMID:  9141529     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Benign prostatic hyperplasia (BPH) is a common disease of aging men. Current medical treatment for this condition is only partially effective, therefore many patients must undergo surgery for symptomatic relief. BPH is caused by an increase in prostate epithelial and stromal cells, especially the latter. Since BPH stromal cells have a long life span and are not very responsive to androgen withdrawal, cultured BPH stromal cells were used to explore the feasibility of pharmacologically inducing apoptosis in these cells. We obtained BPH tissue during surgery, and stromal cells were isolated and maintained in culture. After cells achieved confluence, we induced apoptosis with the HMGCoA reductase inhibitor, lovastatin (30 micromol/L). The effects of testosterone (100 micromol/L), dihydrotestosterone (DHT; 100 micromol/L) and finasteride (100 micromol/L) on lovastatin-induced apoptosis were studied on cells grown in media containing charcoal stripped serum. Similarly, we examined the effect of the cholesterol pathway metabolites, mevalonic acid (30 micromol/L), geranyl geraniol (30 micromol/L), farnesol (10 micromol/L), squalene (30 micromol/L) and 7-ketocholesterol (3 micromol/L) on lovastatin-induced apoptosis. We demonstrated apoptosis by DNA laddering in agarose gels, by fluorescence microscopy following acridine orange staining, and by flow cytometry after end-labeling of DNA strand breaks with biotin-16-dUTP using deoxynucleotidyl exotransferase (TdT). Lovastatin at 30 micromol/L, but not at lower concentrations, induced apoptosis in BPH prostate stromal cells. This was seen (by flow cytometry) in 16.6 +/- 7.3% (mean +/- SD) of BPH cells treated with lovastatin at 72 h vs. 2.5 +/- 1.2% of cells treated with ethanol. Lovastatin-induced apoptosis was not increased in stripped serum or by the addition finasteride, and was not inhibited by testosterone or DHT. Only mevalonate and geranyl geraniol, prevented lovastatin-induced apoptosis whereas farnesol, squalene, or 7-ketocholesterol did not. We conclude that lovastatin can induce apoptosis in BPH stromal cells in vitro, and this is not affected by androgen withdrawal or stimulation. It is unlikely that lovastatin, per se, will be an effective treatment for BPH in vivo, but it does provide a means for inducing apoptosis in vitro. Understanding the apoptotic process in BPH stromal cells ultimately may lead to new therapeutic strategies for BPH.
Authors:
S J Padayatty; M Marcelli; T C Shao; G R Cunningham
Related Documents :
20973789 - Proliferative and necrotising otitis in a kitten: first demonstration of t-cell-mediate...
20596749 - Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulatio...
12851709 - Sesquiterpenes (costunolide and zaluzanin d) isolated from laurel (laurus nobilis l.) i...
20923189 - The flavonol isorhamnetin exhibits cytotoxic effects on human colon cancer cells.
12894879 - Detection of b lymphoma cells undergoing apoptosis by annexin-v assay.
25245029 - The three-way switch operation of rac1/rhoa gtpase-based circuit controlling amoeboid-h...
11189949 - Use of myocardial imaging agents for tumour diagnosis--a success story?
12941329 - Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives impro...
21865299 - Functional and physical interaction between the mismatch repair and fa-brca pathways.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  82     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1997 May 
Date Detail:
Created Date:  1997-05-23     Completed Date:  1997-05-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1434-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, VA Medical Center, and Baylor College of Medicine, Houston, Texas 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis*
Cholesterol / metabolism
DNA / metabolism
Dihydrotestosterone / pharmacology
Diterpenes / pharmacology
Enzyme Inhibitors / pharmacology*
Finasteride / pharmacology
Flow Cytometry
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Kinetics
Lovastatin / pharmacology*
Male
Mevalonic Acid / pharmacology
Prostate / pathology*
Prostatic Hyperplasia / pathology*
Stromal Cells / pathology*
Testosterone / pharmacology
Chemical
Reg. No./Substance:
0/Diterpenes; 0/Enzyme Inhibitors; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 150-97-0/Mevalonic Acid; 521-18-6/Dihydrotestosterone; 57-88-5/Cholesterol; 58-22-0/Testosterone; 75330-75-5/Lovastatin; 7614-21-3/geranylgeraniol; 9007-49-2/DNA; 98319-26-7/Finasteride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human Leydig cells and Sertoli cells are producers of interleukins-1 and -6.
Next Document:  Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.